the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator.#sunpharma #halolfacility #usfda #cnbctv18 # ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment of its cleaning effectiveness and cross-contamination hazards. The company was given 15 working ...

Sun Pharmaceutical Industries posted a 5.2 percent year-on-year (YoY) rise in net profit for the third quarter of Financial ...

Sun Pharma and Concert expect to complete the transaction later in the current quarter. If deuruxolitinib reaches the market, it would compete against Eli Lilly’s Olumiant, which the FDA ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharmaceutical Industries, a leading Indian pharma giant with revenues of over Rs. 38,400 crore plus, has posted consolidated revenue growth of 14 per cent during the third quarter ended December ...

But Indian sport, for the better or the worse, has had no... A US-based unit of Sun Pharma is recalling 50,680 vials of Testosterone Cypionate Injection, used to treat low testosterone in adult ...

The suit accuses LGM Pharma LLC, headquartered at 6400 Congress ... The company also imported ingredients from suppliers on the FDA’s Import Alerts list, which gives the agency authority to ...

Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of $8 per share in cash. Sun Pharmaceutical Industries, the world’s fourth-largest ...

Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million. The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that ...